Clinical trial
Insulin Resistance in Patients With Mood Disorder
NCT00242619 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00242619 |
|---|---|
| Title | Insulin Resistance in Patients With Mood Disorder |
| Official title | Rosiglitazone Add-On in Treatment of Depressed Patients With Insulin Resistance: a Pilot Study |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Depression, Bipolar Disorder, Insulin Resistance |
| Intervention type | Drug |
| Interventions | rosiglitazone |
| Enrollment | 12 |
| Start date | Jul 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Oct 20, 2005 |
| Last update posted | Feb 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: